118 related articles for article (PubMed ID: 9284189)
1. The urological management of men with lower urinary tract symptoms, recorded using an interactive computer program.
Hansen MV; Zdanowski A
Br J Urol; 1997 Aug; 80(2):205-10. PubMed ID: 9284189
[TBL] [Abstract][Full Text] [Related]
2. The American Urological Association symptom score in the evaluation of men with lower urinary tract symptoms: at 2 years of followup, does it work?
Kaplan SA; Olsson CA; Te AE
J Urol; 1996 Jun; 155(6):1971-4. PubMed ID: 8618299
[TBL] [Abstract][Full Text] [Related]
3. Variations in the diagnostic process among urologists in one region recorded using an interactive computer program.
Gewalli F; Hansen MV
Scand J Urol Nephrol; 1998 Feb; 32(1):36-41. PubMed ID: 9561572
[TBL] [Abstract][Full Text] [Related]
4. The agreement among urological experts on the diagnostic management of patients with common urological problems.
Hansen MV; Zdanowski A
Br J Urol; 1997 Nov; 80(5):787-92. PubMed ID: 9393304
[TBL] [Abstract][Full Text] [Related]
5. Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function.
Miner M; Rosenberg MT; Perelman MA
Clin Ther; 2006 Jan; 28(1):13-25. PubMed ID: 16490576
[TBL] [Abstract][Full Text] [Related]
6. Urologists' attitudes to sexual complications of LUTS/BPH treatments.
Giona S; Ganguly I; Muir G
World J Urol; 2018 Sep; 36(9):1449-1453. PubMed ID: 29680951
[TBL] [Abstract][Full Text] [Related]
7. Lower urinary tract symptoms and erectile dysfunction; links for diagnosis, management and treatment.
Ponholzer A; Madersbacher S
Int J Impot Res; 2007; 19(6):544-50. PubMed ID: 17611608
[TBL] [Abstract][Full Text] [Related]
8. [Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association].
Descazeaud A; Robert G; Delongchamps NB; Cornu JN; Saussine C; Haillot O; Devonec M; Fourmarier M; Ballereau C; Lukacs B; Dumonceau O; Azzouzi AR; Faix A; Desgrandchamps F; de la Taille A;
Prog Urol; 2012 Dec; 22(16):977-88. PubMed ID: 23178093
[TBL] [Abstract][Full Text] [Related]
9. [Variation in the diagnosis and treatment of benign prostatic hyperplasia in urological practice].
Stoevelaar HJ; van de Beek C; Casparie AF; Nijs HG; McDonnell J; Janknegt RA
Ned Tijdschr Geneeskd; 1996 Apr; 140(15):837-42. PubMed ID: 8668278
[TBL] [Abstract][Full Text] [Related]
10. Doxazosin for treating lower urinary tract symptoms compatible with benign prostatic obstruction: a systematic review of efficacy and adverse effects.
MacDonald R; Wilt TJ; Howe RW
BJU Int; 2004 Dec; 94(9):1263-70. PubMed ID: 15610102
[TBL] [Abstract][Full Text] [Related]
11. Benign prostatic hyperplasia: a review.
Ramsey EW
Can J Urol; 2000 Dec; 7(6):1135-43. PubMed ID: 11151094
[TBL] [Abstract][Full Text] [Related]
12. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction.
Oelke M; Bachmann A; Descazeaud A; Emberton M; Gravas S; Michel MC; N'dow J; Nordling J; de la Rosette JJ;
Eur Urol; 2013 Jul; 64(1):118-40. PubMed ID: 23541338
[TBL] [Abstract][Full Text] [Related]
13. Medical management of lower urinary tract symptoms in men: current treatment and future approaches.
Patel AK; Chapple CR
Nat Clin Pract Urol; 2008 Apr; 5(4):211-9. PubMed ID: 18301417
[TBL] [Abstract][Full Text] [Related]
14. Economic modeling to assess the costs of treatment with finasteride, terazosin, and transurethral resection of the prostate for men with moderate to severe symptoms of benign prostatic hyperplasia.
Lowe FC; McDaniel RL; Chmiel JJ; Hillman AL
Urology; 1995 Oct; 46(4):477-83. PubMed ID: 7571214
[TBL] [Abstract][Full Text] [Related]
15. Effects of a shared protocol between urologists and general practitioners on referral patterns and initial diagnostic management of men with lower urinary tract symptoms in Italy: the Prostate Destination study.
Spatafora S; Canepa G; Migliari R; Rotondo S; Mandressi A; Puppo P;
BJU Int; 2005 Mar; 95(4):563-70. PubMed ID: 15705081
[TBL] [Abstract][Full Text] [Related]
16. Management of symptomatic BPH in the US: who is treated and how?
Bruskewitz R
Eur Urol; 1999; 36 Suppl 3():7-13. PubMed ID: 10559625
[TBL] [Abstract][Full Text] [Related]
17. Current trends in management of men with lower urinary tract symptoms and benign prostatic hyperplasia.
Holtgrewe HL
Urology; 1998 Apr; 51(4A Suppl):1-7. PubMed ID: 9586589
[TBL] [Abstract][Full Text] [Related]
18. The short-term and long-term effects of radical prostatectomy on lower urinary tract symptoms.
Slova D; Lepor H
J Urol; 2007 Dec; 178(6):2397-400; discussion 2400-1. PubMed ID: 17936841
[TBL] [Abstract][Full Text] [Related]
19. Lifestyle and behavioural interventions for men on watchful waiting with uncomplicated lower urinary tract symptoms: a national multidisciplinary survey.
Brown CT; Van Der Meulen J; Mundy AR; Emberton M
BJU Int; 2003 Jul; 92(1):53-7. PubMed ID: 12823383
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of male sexual function in patients with Lower Urinary Tract Symptoms (LUTS) associated with Benign Prostatic Hyperplasia (BPH) treated with a phytotherapeutic agent (Permixon), Tamsulosin or Finasteride.
Zlotta AR; Teillac P; Raynaud JP; Schulman CC
Eur Urol; 2005 Aug; 48(2):269-76. PubMed ID: 15939527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
